Nexstim Plc22.03.2017 14:15:00 CET
Company Announcement, Helsinki, 22 March 2017, 15:15 pm
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation, announces that the Nomination Committee will propose to the annual general meeting of Nexstim Plc that Tomas Holmberg will be elected as the fifth member of the Board of Director's. Tomas Holmberg's CV can be found from http://www.nexstim.com/investors/shareholder-meetings/.
NEXSTIM PLC
Martin Jamieson, Chairman and CEO
For further information please visit www.nexstim.com or contact:
Nexstim +447715163942
Martin Jamieson, Chairman and CEO martin.jamieson@nexstim.com
UB Securities Oy (Certified Adviser) +358 (0)9 2538 0246
Citigate Dewe Rogerson +44 (0)207 2821066
Katja Stout katja.stout@citigatedr.co.uk
About Nexstim Plc
Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the company has developed a system called Navigated Brain Therapy (NBTŪ) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com